Consent, Communication and Commercial Risk
The Brief — Vol.I No.7
What your patient documentation is telling people about your brand — and your judgment
Pull out your consent form.
Not the one you intend to review when you have time. The one your patients are actually signing today, in your clinic, before their treatment.
Read the first paragraph as though you are reading it for the first time — as a patient with no medical background, who is about to allow someone to inject their face, and who is holding this document as the primary written communication they have received from your practice.
What does it tell them about who you are?
In most aesthetic clinics, the honest answer is: not much that is reassuring, and several things that are counterproductive. The language is often legalistic, the layout perfunctory, the tone risk-transfer rather than care-expression. The document that should be communicating clinical precision, patient orientation, and honest professionalism is instead communicating that someone, at some point, downloaded a template and forgot about it.
This matters more commercially than most practitioners realise — and it carries regulatory dimensions that the template approach does not adequately address.
The document as a brand event
In Vol.I No.3, the consultation and consent process was identified as the fifth of seven critical patient touchpoints — a moment in which the quality of a practitioner's judgment and care is communicated not just clinically but experientially. The consent document is the physical artefact of that moment. It is, in many respects, the most intimate piece of brand communication a clinic produces: it is placed in a patient's hands at the point of highest vulnerability, when they are about to make a decision that involves trust, physical risk, and personal investment.
Salesforce's research into customer experience across service industries finds that the quality of documentation — contracts, agreements, formal communications — is among the strongest secondary signals of organisational quality.¹ In healthcare specifically, where patients have limited ability to assess clinical skill directly, the standard of written communication functions as a proxy for the standard of clinical practice. A consent form that is clear, specific, and warm in its language is communicating something about the practitioner who produced it. So is one that is generic, cluttered, and cold.
The implication is not merely aesthetic. Patient psychology research consistently finds that the quality of informed consent communication — the degree to which patients feel they have been genuinely informed rather than procedurally processed — is a significant predictor of treatment satisfaction, complaint behaviour, and the likelihood of return.² A patient who signs a consent form they do not fully understand, or that does not address the questions they actually have, is a patient who has not been genuinely consented. Regardless of the legal signature on the form, that gap creates both a clinical and a commercial risk.
What AHPRA and the TGA actually require
The regulatory framework governing aesthetic medicine communications in Australia is not merely a set of restrictions. It is, properly understood, a framework for the kind of honest, patient-oriented communication that good clinical practice requires in any case.
AHPRA's guidelines for advertising a regulated health service are specific about what registered practitioners may and may not communicate.³ Testimonials that create unrealistic expectations about treatment outcomes are prohibited. Before-and-after imagery is subject to significant restrictions. Claims that a treatment can achieve outcomes that cannot be substantiated are a breach. These restrictions are not bureaucratic inconveniences. They reflect a considered position about what patients need from healthcare communications in order to make genuinely informed decisions.
The Therapeutic Goods Administration's advertising code applies to any therapeutic claim made in connection with a scheduled medicine or a therapeutic device.⁴ In aesthetic medicine, this is directly relevant to communications about anti-wrinkle injectables, dermal fillers, and a range of energy-based devices. Claims about efficacy, superiority, or specific outcomes that go beyond what the TGA has approved for the relevant product are not merely imprudent — they are potential breaches of the Therapeutic Goods Act, with consequences that include formal warnings, enforceable undertakings, and referral to the relevant professional board.
What is striking about both frameworks is how closely they align with good communication practice. The clinic whose communications honestly describe what a treatment can and cannot achieve, which avoids claims it cannot substantiate, and which presents patient outcomes in realistic and contextually accurate terms, is not merely compliant. It is demonstrating precisely the quality of clinical judgment that patients are looking for when they evaluate a provider.
Compliance and trustworthiness are making the same argument.
Where documentation fails in practice
The most common failures in aesthetic clinic documentation are not malicious. They are the result of inattention — of documents that were created once and never reviewed, systems that have grown without anyone auditing what they actually communicate.
Consent forms are the most frequently deficient. The common failures include: language that is legalistic without being informative; risk statements that are technically accurate but practically incomprehensible to a non-clinical reader; absence of specific information about the treatment being consented to (generic forms used across multiple procedures); no reference to the practitioner who will be performing the treatment; and no clear articulation of what the patient should do if they have concerns during their recovery.
Each of these failures is a communication failure before it is a compliance failure. A patient who signs a consent form they have not genuinely understood has not been informed. The signature on the page is a legal instrument, but it is not a substitute for the communication it was designed to document.
Treatment menus and pricing documents carry their own communication risks. In the rush to present a comprehensive service offering, many clinics produce treatment menus that communicate confusion rather than confidence — long lists of procedures with no organising logic, pricing presented without context, descriptions that use clinical terminology without explanation. A treatment menu is a brand document. It tells a patient what a clinic values, how it thinks about its work, and whether it has considered the patient's experience of navigating its services.
Aftercare documentation is frequently the weakest link in the patient communication chain. Generic aftercare sheets — often printed from supplier materials or downloaded from professional organisations — fail to communicate the specific context of the individual treatment, the practitioner's particular post-procedure preferences, or the specific signs that should prompt the patient to make contact. They also miss the opportunity, at the moment of highest patient engagement with the practice, to communicate warmth, specificity, and genuine care.
The commercial cost of documentation failure
The commercial case for investing in documentation quality is not difficult to make, but it requires looking beyond the individual transaction.
Research into complaint behaviour in healthcare consistently finds that complaints — formal and informal — are disproportionately generated not by poor clinical outcomes but by poor communication around clinical outcomes.⁵ Patients who understood what to expect, who felt genuinely informed and heard, and whose recovery experience was supported by clear and warm communication are significantly less likely to complain when an outcome is imperfect than patients who felt procedurally processed and inadequately prepared.
The medicolegal dimension is significant. Medical Defence Organisation guidance across Australia and New Zealand consistently identifies inadequate informed consent documentation as a primary factor in adverse medicolegal outcomes — not because the treatment caused harm, but because the practitioner cannot demonstrate that the patient was genuinely informed of the possibility.⁶ Good documentation is not merely protective in an abstract sense. It is, in specific and documentable ways, the practitioner's best defence in any dispute about what was communicated before a treatment took place.
And the retention and referral dimension is equally concrete. A patient who leaves a clinic with aftercare documentation that is clear, specific, and warm — that communicates that the practitioner was thinking about their recovery as well as their treatment — is more likely to return and more likely to refer than one who leaves with a generic printed sheet. The quality of the document is carrying the quality of the relationship into the period after the appointment ends.
Three things you can do this week
The consent form, the treatment menu, the aftercare sheet — these documents are not administrative necessities waiting to be filled in and forgotten. They are communications. They are being read by patients at moments of significant personal vulnerability, and they are telling those patients something about the quality of the practice they have chosen.
That communication is either designed or it is left to chance. In a practice where the clinical work is the result of years of training, continuous professional development, and genuine commitment to patient outcomes, leaving the documentation to chance is a disproportion that the practice cannot afford — commercially, reputationally, or professionally.
Three places to begin:
Read your consent form as a patient. Print your current consent form and read it in full, as though you are a patient with no clinical background reading it for the first time before a treatment you are anxious about. Mark every sentence that is unclear, every term that is unexplained, and every section where you would, as a patient, want more specific information. Then identify whether the document as a whole communicates the standard of care your clinical work represents — or whether it communicates something considerably less considered. That gap is your starting point.
Cross-reference one piece of communication against AHPRA's advertising guidelines. Take the most recent patient-facing communication your clinic has published — a social media post, a treatment description on your website, a promotional email — and read it against the current AHPRA advertising guidelines, available on the AHPRA website at no cost. Specifically check: does it include or imply patient testimonials? Does it make claims about outcomes that cannot be substantiated? Does it use before-and-after imagery, and if so, does that imagery comply with the current guidelines? This exercise takes approximately 30 minutes and will tell you more about your compliance exposure than any external audit.
Rewrite your aftercare document for one treatment. Choose your most commonly performed procedure and write a new aftercare document specifically for it — not adapted from a template, written from scratch. Address: what the patient is likely to experience in the first 24, 48, and 72 hours. What is normal and what is not. A specific action to take if they have concerns, with a direct contact and a named person. And one sentence that communicates, in the clinic's voice, that their recovery matters to you. The document should be one page, simply laid out, and warm without being informal. That document is both better clinical practice and better brand communication than what most clinics currently send their patients home with.
References
Salesforce Research. State of the Connected Customer. 5th ed. 2023–2024.
Coulter, A. & Ellins, J. "Effectiveness of Strategies for Informing, Educating, and Involving Patients." BMJ.335(7609), 2007.
Australian Health Practitioner Regulation Agency (AHPRA). Guidelines for Advertising a Regulated Health Service. Current edition.
Therapeutic Goods Administration (TGA). Therapeutic Goods Advertising Code. Current edition.
Vincent, C., Young, M. & Phillips, A. "Why Do People Sue Doctors? A Study of Patients and Relatives Taking Legal Action." The Lancet. 343(8913), 1994.
Medical Defence Association of Australia (MDAA). Informed Consent: Guidance for Practitioners. Current edition.
The Aesthetic Collective provides brand strategy, communications, and marketing services to aesthetic medicine clinics across Australia and New Zealand.